Democratic Senators Press RFK Jr. Over Undisclosed Shift of Law Firm Fees to Wisner Baum

What happened

Four Democratic senators are demanding answers from Health and Human Services Secretary Robert F. Kennedy Jr. about a previously undisclosed change to his pre-confirmation ethics agreement involving contingency fees from litigation against the maker of a cervical cancer vaccine.

Sens. Elizabeth Warren of Massachusetts, Ron Wyden of Oregon, Richard Blumenthal of Connecticut and Angela Alsobrooks of Maryland sent the letter to Kennedy on Thursday, Sept. 25, 2026, according to an Associated Press report carried by WBAL NewsRadio 1090. The letter concerns fees Kennedy stood to collect from lawsuits he had pursued against the makers of Gardasil, a cervical cancer vaccine, before he became HHS secretary.

Before his confirmation vote, Kennedy told lawmakers he would not collect those fees, saying he would transfer his financial interests to his adult son, Conor Kennedy. His initial ethics disclosure, filed in January 2025, had allowed him to retain a 10% contingency fee in cases he referred to his former employer, the personal injury law firm Wisner Baum. After conflict-of-interest warnings from lawmakers during the confirmation process, he agreed to divest that interest to his son.

The dispute centers on what happened next. In an Aug. 25 letter to Sen. Warren, HHS revealed that Kennedy instead "irrevocably assigned his outstanding contingency-fee interests in the Gardasil cases directly to Wisner Baum," the firm where Conor Kennedy is employed. The department's letter explained the reversal this way: "At the time, Secretary Kennedy intended to assign those interests to a non-dependent adult family member. After further consideration, Secretary Kennedy irrevocably assigned his outstanding contingency-fee interests in the Gardasil cases directly to Wisner Baum."

The senators wrote in their letter that Kennedy's "decision to withhold this information from Congress and apparent failure to report this change to agency ethics officials is deeply alarming." They said the episode "call[s] into question the veracity of your public ethics commitments, your transparency with Congress and the public, and potentially, your compliance with federal ethics disclosure laws and regulations."

The letter also raised the possibility of a continuing financial stake. "If you made any kind of implicit or explicit agreement for future payment or other future rewards with Wisner Baum in exchange for assigning them this stake, it would mean that you have an ongoing conflict of interest that calls into question your integrity and the motivations for your decisions as HHS Secretary," the senators wrote, according to the AP report carried by the Winnipeg Free Press.

Kennedy did not immediately respond to AP requests for comment on Friday. HHS, in its Aug. 25 letter, framed the change as a considered decision rather than a disclosure failure, saying the secretary reevaluated his original plan to assign the interests to a family member before transferring them directly to the firm.

Why it matters

The letter puts renewed attention on the ethics commitments Kennedy made to senators before his confirmation, commitments that have faced prior scrutiny. The AP notes that Kennedy pledged during his confirmation testimony to maintain vaccine policies he later moved to change, and that his claim that a 2019 trip to Samoa had "nothing to do with vaccines" was refuted by documents the news agency recently obtained. HHS has denied that Kennedy lied about the Samoa trip.

The senators' core argument is procedural as well as substantive: they contend the change was not disclosed to Congress when it was made and may not have been reported to agency ethics officials, raising questions about whether federal ethics disclosure laws and regulations were followed. The department's account, that Kennedy simply reconsidered and chose a different recipient for the interests, does not address why the reassignment to Wisner Baum was not disclosed until an Aug. 25 letter, roughly a month before the senators' inquiry became public.

The stakes extend beyond one agreement. The senators warn that any arrangement for future payment from the firm would constitute an ongoing conflict of interest bearing on "the motivations for your decisions as HHS Secretary," an assertion that goes to the integrity of the department's leadership on vaccine and public health policy, the very area where Kennedy's confirmation pledges have already drawn scrutiny.

How it is being covered

According to ground.news, the story is carried by 14 outlets with a left/centre/right split of 31/46/23%, and 13 of the 14 sources are rated high or very high for factuality. Coverage skews toward centre and left outlets, with the AP wire account forming the backbone of most reports. Ground.news flags no blindspot, meaning no side of the spectrum is absent from coverage, though the volume on the right is the smallest of the three groups.

What to watch

Watch for a response from Kennedy or HHS to the senators' letter, particularly on whether the change was reported to agency ethics officials and when. Watch also whether the senators escalate beyond a letter, for example through a hearing or a request to ethics overseers, and whether any evidence emerges of an agreement for future payment from Wisner Baum, the scenario the letter says would constitute an ongoing conflict of interest. Additional reporting on Kennedy's confirmation testimony, including the AP's recently obtained documents on the 2019 Samoa trip, may shape how the ethics questions are framed going forward.

By the numbers

Source snapshot